본문으로 건너뛰기
← 뒤로

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Nature communications 2026 Vol.17(1)

Huff AL, Haldar SD, Girgis AA, Wang HH, Danilova L, Heumann T, Berg M, Wang Y, Andaloori L, Hernandez A, Longway G, Barrett B, Zhu Z, Davis-Marcisak E, Thoburn C, Leatherman J, Mitchell S, Lee JW, Shu DH, Konig MF, Mog BJ, Montagne J, Coyne EM, Bever K, Baretti M, Yarchoan M, Anders RA, Kagohara LT, Laheru D, Thomas AM, Durham J, Nauroth JM, Lu J, Wang H, Fertig EJ, Ho WJ, Azad NS, Jaffee EM, Zaidi N

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Huff AL, Haldar SD, et al. (2026). Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.. Nature communications, 17(1). https://doi.org/10.1038/s41467-026-71968-x
MLA Huff AL, et al.. "Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.." Nature communications, vol. 17, no. 1, 2026.
PMID 41986375

같은 제1저자의 인용 많은 논문 (1)